The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Pharmacokinetic analysis of tamoxifen metabolites in premenopausal women with early breast cancer: A substudy of NCIC CTG MA.12 randomized clinical trial.
Shahbal Bill Kangarloo
No relevant relationships to disclose
Ella S.M. Ng
No relevant relationships to disclose
Vivien H.C. Bramwell
No relevant relationships to disclose
Kathleen I. Pritchard
No relevant relationships to disclose
Lois E. Shepherd
No relevant relationships to disclose
Dongsheng Tu
No relevant relationships to disclose
Anthony M. Magliocco
No relevant relationships to disclose
Patricia A. Tang
No relevant relationships to disclose